Status:
COMPLETED
Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Funds for Research in Ophthalmology (FRO) of Belgium
Novartis
Conditions:
Vernal Keratoconjunctivitis
Eligibility:
All Genders
5+ years
Phase:
PHASE4
Brief Summary
Vernal keratoconjunctivitis (VKC) is a bilateral, chronic, external ocular inflammatory disease of unknown cause. It is a fairly common disease in hot, dry environments, representing as much as 3% of ...
Eligibility Criteria
Inclusion
- \- at least 5 years of age
Exclusion
- being pregnant
- suffering from any other infectious or inflammatory ocular pathology
- using topical/ systemic corticosteroids, antihistamines, non-steroidal anti-inflammatory drugs or immunosuppressives 2 weeks prior to the trial
- been treated with steroid injection 6 months prior to the study
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT01211327
Start Date
July 1 2008
End Date
November 1 2008
Last Update
September 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kabgayi Hospital
Gitarama/Muhanga, Rwanda